Sware

GxPNext provides agentic GxP validation for software developers and embeds compliance into the SDLC for regulated life sciences software.

The Sware GxP Suite includes Res_Q, the intelligent GxP validation platform, and GxPNext, agentic validation for software developers.

Res_Q is the intelligent electronic validation software for life sciences, combining agentic validation with a decade of regulated knowledge.

The page covers change management frameworks, practices, and case studies for transformation in life sciences and the pharmaceutical industry.

The page compares CSA and CSV, including their regulatory implications, documentation processes, and cost advantages, and discusses which approach may suit different needs.

Join Bryan Ennis and Jeff Brittain, Former Head of IT at Bayer, as they explore how pharma leaders can separate real AI value from industry hype—without compromising GxP and compliance requirements.

The page covers strategies for pharmaceutical content management compliance, including software, technology, and processes in the life sciences industry.

The page describes careers focused on changing how life sciences companies achieve GxP compliance.

The page describes Sware’s approach to GxP compliance for life sciences leaders.

The page provides news on intelligent GxP validation, industry insights, and upcoming events.

Sware works closely with partners who are committed to driving quality excellence and are never satisfied with the status quo.

Sign-up now for an efficient review of Res_Q by Sware to learn how to automate validation and be ever audit-ready.

The Sware GxP Suite is a unified GxP validation software for life sciences. Res_Q for validation teams, GxPNext for software developers.

The Sware Privacy Policy describes how Sware collects, uses, and discloses information when people interact with Sware.com.